About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 13655 record(s)
Req # A-2019-002063
Adverse Drug Reaction (ADR) for IXAZOMIB. Report number: E2B_02897412.Organization: Health Canada
February 2022
Req # A-2020-000057
Adverse Drug Reaction (ADR). Report number: 02517334.Organization: Health Canada
February 2022
Req # A-2020-000078
Adverse Drug Reaction (ADR) for VANDETANIB. Report number: E2B_02536410.Organization: Health Canada
February 2022
Req # A-2021-000354
Adverse Drug Reaction (ADR) for AMLODIPINE BESILATE. Report number: E2B_03566994.Organization: Health Canada
February 2022
Req # A-2021-001066
Adverse Drug Reaction (ADR) for INSULIN GLARGINE. Report number: E2B_03861558.Organization: Health Canada
February 2022
Req # A-2021-001191
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-111766-914, COVID-19 Mass Vaccination Advertising Campaign.Organization: Health Canada
February 2022
Req # A-2021-001228
Adverse Drug Reaction (ADR) for LEVOMEPROMAZINE. Report number: E2B_03452251.Organization: Health Canada
February 2022
Req # A-2021-001345
Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B 03482529.Organization: Health Canada
February 2022
Req # A-2021-001347
Adverse Drug Reaction (ADR) for INFLUENZA VACCINE. Report number: E2B_03813844.Organization: Health Canada
February 2022
Req # A-2021-001413
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03523653, E2B_03676080.Organization: Health Canada
February 2022